Ganoderma Lucidum production of pharmaceuticals

Bioprocess Sciences and Technology

Volumn , Issue , 2011, Pages 231-266

  Boh, B ^a   Berovic, M ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892055329     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (173)

1. Wasser, S. P. 2002. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied Microbiology And Biotechnology, 60, 258-274.
2. Chen, J. Z. & Seviour, R. 2007. Medicinal importance of fungal β-(1-3), (1-6)-glucans. Mycological Research, 111, 635-652.
3. Moradali, M. F., Mostafavi, H., Ghods, S. & Hedjaroude, G. A. 2007. Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi), International Immunopharmacology, 7, 701-724.
4. FreePatentsOnline-Search patents, URL http://www.freepatentsonline.com/search.html. Accessed 25/1/2010.
5. Yang, F. C. & Liau, C. B. 1998. The influence of environmental conditions on polysaccharide formation by Ganoderma lucidum in submerged cultures. Process Biochemistry, 33, 547-553.
6. Berovic, M., Habijanic, J., Zore, I., Wraber, B., Hodzar, D., Boh, B. & Pohleven, F. 2003. Submerged cultivation of Ganoderma lucidum biomass and immunostimulatory effects of fungal polysaccharides. Journal of Biotechnology, 103, 77-86.
7. Gibbs, P. A., Seviour R. J., & Schmid F. 2000. Growth of filamentous fungi in submerged culture: Problems and possible solutions. Critical Reviews in Biotechnology, 20, 17-48.
8. Papagianni, M. 2004. Fungal morphology and metabolite production in submerged mycelial processes. Biotechnology Advances, 22, 189-259.
9. Habijanic, J. & Berovic, M. 2000. The relevance of solid-state substrate moisturing on Ganoderma lucidum biomass cultivation. Food Technology and Biotechnology, 38, 225-228.
10. Berovic, M. & Popovic M., 2001. Characterisation of gas mixed bioreactors in submerged citric acid fermentation. Chemical and Biochemical Engineering Quarterly, 15, 65-69.
11. Schugerl, K., Wittler, R. & Lorenz, T. 1983. The use of mold in pellet form. Trends in Biotechnology, 1, 120-123.
12. Berovic, M., 2007. Bioreactor Types. In: Encyclopedia of life support systems [online] URL http://www.eolss.net/outlinecomponents/Biotechnology.aspx. 31 pp. Oxford, UK: Eolss Publishers.
13. Wagner R., Mitchell D. A., Lanzi Sassaki G., Lopes de Almeida Amazonas M. A. & Berovic, M. 2003. Submerged Cultivation of Ganoderma lucidum, Food Technology and Biotechnology, 41, 371-382.
14. Hu, C., Meguro, S. & Kawachi, S. 2004. Effects of physical properties of wood on the water activity of wood meal media for the cultivation of edible mushrooms. Journal of Wood Science, 50, 365-370.
15. Abdullah, A. L., Tengerdy, R. P. & Murphy, V. G. 1984. Optimization of solid substrate fermentation of wheat straw. Biotechnology and Bioengineering, 27, 20-27.
16. Mitchell, D. A., Berovic M. & Krieger N. 2006. Introduction to solid-state fermentation bioreactors. In: Solid-State Fermentation Bioreactors: Fundamentals of Design and Operation (edited by D. A., Mitchell, N. Krieger, M. Berovic). Pp. 33-44. Berlin, Germany: Springer.
17. Lonsane, B. K., Saucedo-Castaneda, G., Raimbault, M., Roussos, S., Viniegra-Gonzalez, G., Ghildyal, N. P., Ramakrishna, M. & Krishnaiah, M. M. 1992. Scale-up strategies for solid state fermentation systems. Process Biochemistry, 27, 259-273.
18. Berovic, M. & Ostroversnik, H. 1997. Production of Aspergillus niger pectolytic enzymes by solid state bioprocessing of apple pomace. Journal of Biotechnology, 53, 47-53.
19. Svagelj, M., Berovic, M., Boh, B., Menard, A., Simcic, S. & Wraber, B. 2008. Solid-state cultivation of Grifola frondosa (Dicks: Fr) S.F. Gray biomass and immunostimulatory effects of fungal intra-and extracellular β-polysaccharides. New Biotechnology, 25, 150-155.
20. Mitchell, D.A. & Berovic, M. 2005. Solid state bioprocessing. In: Biochemical engineering principles (edited by M. Berovic & A.W. Nienow). Pp. 204-236. Ljubljana, Slovenia: University of Ljubljana, FKKT Press.
21. Jong, S. C. & Birmingham, J. M. 1992. Medicinal benefits of the mushrooms Ganoderma. Advances in Applied Microbiology, 37, 101-134.
22. Leung, S. W. S. 2002. Lingzhi (Ganoderma) research-the past, present and future perspectives. In Ganoderma: Genetics, chemistry, pharmacology and therapeutics, Proceedings of International symposium on Ganoderma research, October 21-23, 2002 (edited by Z. B. Lin). Pp. 1-9. Shanghai, China: Beijing, Medical University Press.
23. Kim, H.W. & Kim, B.K. 2002. Recent advances on the biologically active triterpenoids of Ganoderma lucidum. In Ganoderma: Genetics, chemistry, pharmacology and therapeutics, Proceedings of International symposium on Ganoderma research, October 21-23, 2002 (edited by Z.B. Lin). Pp. 10-19. Shanghai, China: Beijing, Medical University Press.
24. Liu, G. T., Bao, X., Niu, S., Li, Z. & Sung, Z. 1979. Some pharmacological actions of the spores of Ganoderma lucidum and the mycelium of Ganoderma capense (Lloyd) Teng cultivated by submerged fermentation. Chinese Medical Journal, 92, 469-500.
25. Maruyama, H., Yamazaki, K., Murofushi, S., Konda, C. & Ikekawa, T. 1989. Antitumor activity of Sarcodon aspratus (Berk.) S. Ito and Ganoderma lucidum (Fr.) Karst. Journal of Pharmacobio-Dynamics, 12, 118-123.
26. Tasaka, K., Akag, M., Miyoshi, K., Mio, M. & Makino, T. 1988. Anti-allergic constituents in the culture medium of Ganoderma lucidum. 1. Inhibitory effect of oleic acid on histamine release. Agents and Action, 23, 153-156.
27. Lee, S.Y. & Rhee, H. M. 1990. Cardiovascular effects of mycelium extract of Ganoderma lucidum - inhibition of sympathetic outflow as a mechanism of its hypotensive action. Chemical & Pharmaceutical Bulletin, 38, 1359-1364.
28. Hirose, K., Muto, S., Niimura, K., Ohara, M., Oguchi, Y., Matsunaga, K., Kadochi, J., Sugita, N., Furushu, T., Yoshikumi, C. & Takahashi, M. 1988. Antiviral agent. Japanese patent JP 63316734. 1988 December 26.
29. Mizumoto, K., Yamashita, A., Kii, M. & Sumio, H. 1990. Antiretrovirus agent. Japanese patent JP 2032026. 1990 February 1.
30. Kino, K., Sone, T., Watanabe, J., Yamashita, A., Tsuboi, H., Miyajima, H. & Tsunoo, H. 1991. Immunomodulator, LZ-8, prevents antibody-production in mice, International Journal of Immunopharmacology, 13, 1109-1115.
31. Van Der Hem, L. G., Van Der Vliet, J. A., Bocken, C. F. M., Kino, K., Hoitsma, A. J & Tax W.J.M. 1995. Ling zhi-8-studies of a new immunomodulating agent, Transplantation (Baltimore), 60, 438-443.
32. Triratana, S., Thaithatgoon, S. & Gawgla, M. 1991. Cultivation of Ganoderma lucidum in sawdust bags. In: Science and Cultivation of Edible Fungi, Proceedings of the 13th International Congress on the Science Cultivation of Edible Fungi, Dublin, 1-6 September 1991 (edited by M.J. Maher). Pp. 567-572, Rotterdam: A. A. Balkema.
33. Stamets P. 2000. Ganoderma lucidum (Wm. Curtis: Fries) Karsten. In: Growing Gourmet and Medicinal Mushrooms. 3rd ed., Pp. 352-366. Berkeley, USA: Ten Speed Press.
34. Kohlmünzer, S., Wegiel, J. & Sitarz, J. 1989. Polysaccharides in mycelial culture of Ganoderma applanatum (Pers.) Pat. Herba Hungarica, 28, 87-94.
35. Zore, I., Berovic, M., Boh, B., Hodzar, D. & Pohleven, F. 1998. Procedure for preparation of inoculum for growing of fungus Ganoderma lucidum by submersion fermentation, Slovenian patent SI 9700014, 1998 August 31.
36. Lin, S. B., Li, C. H., Chen, Y. R., Kan, L. S. & Lee, S. S. 2002. Triterpene extract from Ganoderma lucidum inhibits growth of hepatoma Huh7 cells: involvement of oxidative stress induction. In Ganoderma: Genetics, chemistry, pharmacology and therapeutics, Proceedings of International symposium on Ganoderma research, October 21-23, 2002 (edited by Z.B. Lin). Pp. 176-182. Shanghai, China: Beijing, Medical University Press.
37. Fang, Q.H. & Zhong, J.J. 2002. Effect of initial pH on production of ganoderic acid and polysaccharide by submerged fermentation of Ganoderma lucidum. Process Biochemistry, 37, 769-774.
38. Fang, Q.H. & Zhong, J.J. 2002. Submerged fermentation of higher fungus Ganoderma lucidum for production of valuable bioactive metabolites-ganoderic acid and polysaccharide, Biochemical Engineering Journal, 10, 61-65.
39. Tang, Y. J. & Zhong, J. J. 2002. Fed-batch fermentation of Ganoderma lucidum for hyperproduction of polysaccharide and ganoderic acid, Enzyme and Microbial Technology, 31, 20-28.
40. Tang, Y. J. & Zhong, J. J. 2003. Role of oxygen supply in submerged fermentation of Ganoderma lucidum for production of Ganoderma polysaccharide and ganoderic acid, Enzyme and Microbial Technology, 32, 478-484.
41. Tang, Y. J., Zhang, W. & Zhong, J. J. 2009. Performance analyses of a pH-shift and DOT-shift integrated fed-batch fermentation process for the production of ganoderic acid and Ganoderma polysaccharides by medicinal mushroom Ganoderma lucidum. Bioresource Technology, 100, 1852-1859.
42. Tang, Y. J., Zhang, W. & Zhu, L. W. 2009. Hyperproduction of Ganoderma polysaccharides and ganoderic acid during fermentation of medicinal mushroom Ganoderma lucidum by multi-stage control and induced culture. Journal of Bioscience and Bioengineering, 108, S114-S134.
43. Xu, P., Ding, Z. Y., Qian, Z., Zhao, C. X. & Zhang, K. C. 2008. Improved production of mycelial biomass and ganoderic acid bysubmerged culture of Ganoderma lucidum SB97 using complex media, Enzyme and Microbial Technology, 42, 325-331.
44. Zhang, W. X. & Zhong, J. J. 2010. Effect of oxygen concentration in gas phase on sporulation and individual ganoderic acids accumulation in liquid static culture of Ganoderma lucidum. Journal of Bioscience and Bioengineering, 109, 37-40.
45. Papinutti L. 2010. Effects of nutrients, pH and water potential on exopolysaccharides production by a fungal strain belonging to Ganoderma lucidum complex. Bioresource Technology, 101, 1941-1946.
46. Mizuno, T., Wang, G., Zhang, J., Kawagishi, H., Nishitoba, T. & Li, J. 1995. Reishi, Ganoderma lucidum and Ganoderma tsugae: bioactive substance and medicinal effects, Food Reviews International, 11, 151-166.
47. Miyahara, R., Yoshimoto, T. & Asawa, K. 1987. Chemical structures and changes of extracts during growth of reishi (Ganoderma lucidum), Mokuzai Gakkaishi, 33, 416-422.
48. Chan, K. 2002. Linking chemical and biological characteristics in assuring the quality of Chinese medicinal materials and OTC products. In Ganoderma: Genetics, chemistry, pharmacology and therapeutics, Proceedings of International symposium on Ganoderma research, October 21-23, 2002 (edited by Z.B. Lin). Pp. 24-34. Shanghai, China: Beijing, Medical University Press.
49. Boh, B., Berovic, M., Zhang, J. S. & Lin Z. B. 2007. Ganoderma lucidum and its pharmaceutically active compounds. In: Biotechnology annual review, Vol. 13 (edited by M. R. El-Gewely) pp. 265-301. Amsterdam, Netherlands: Elsevier
50. Shigeru, Y. 1991. Cultivation of Reishi, Japanese patent JP3083521. 1991 April 9.
51. Gonzalez-Matute, R., Figlas, D., Devalis R., Delmastro, S. & Curvetto, N. 2002. Sunflower seed hulls as a main nutrient source for cultivating Ganoderma lucidum. Micologia Aplicada International, 14, 19-24.
52. Yang, F. C., Hsieh, C. & Chen, H. M. 2003. Use of stillage grain from a rice-spirit distillery in the solid state fermentation of Ganoderma lucidum. Process Biochemistry, 39, 21-26.
53. Hsieh, C. & Yang, F.C. 2004. Reusing soy residue for the solid-state fermentation of Ganoderma lucidum. Bioresource Technology, 91, 105-109.
54. Fang, Q.H., Tang, Y.J. & Zhong, J.J. 2002d. Significance of inoculation density control in production of polysaccharide and ganoderic acid by submerged culture of Ganoderma lucidum, Process Biochemistry, 37, 1375-1379.
55. Yang, F. C., Ke, Y. F. & Kuo, S. S. 2000. Effect of fatty acids on the mycelial growth and polysaccharide formation by Ganoderma lucidum in shake-flask cultures. Enzyme and Microbial Technology, 27, 295-301.
56. Simonic, J., Stajic, M., Glamoclija, J. Vukojevic, J., Duletic-Lausevic, S. & Brceski, I. 2008. Optimization of submerged cultivation conditions for extra-and intracellular polysaccharide production by medicinal Ling Zhi or Reishi mushroom Ganoderma lucidum (W. Curt.: Fr.) P. Karst. (Aphyllophoromycetideae). International Journal of Medicinal Mushrooms, 10, 351-360.
57. Hsieh, C., Tseng, M.H. & Liu, C.J. 2006b. Production of polysaccharides from Ganoderma lucidum (CCRC 36041) under limitations of nutrients. Enzyme and Microbial Technology, 38, 109-117.
58. Lee, K. M., Lee, S. Y. & Lee, H. Y. 1999. Bistage control of pH for improving exopolysaccharide production from mycelia of Ganoderma lucidum in an air-lift fermentor. Journal of Bioscience and Bioengineering, 88, 646-650.
59. Fang, J. N., Bao, X.F. & Yuen, W.H. 2002a. Studies on the polysaccharides from spores of Ganoderma lucidum. In Ganoderma: Genetics, chemistry, pharmacology and therapeutics, Proceedings of International symposium on Ganoderma research, October 21-23, 2002 (edited by Z.B. Lin). Pp. 98-103. Shanghai, China: Beijing, Medical University Press.
60. Hsieh, C., Hsu, T.H. & Yang, F.C. 2005. Production of polysaccharides of Ganoderma lucidum (CCRC36021) by reusing thin stillage, Process Biochemistry, 40, 909-916.
61. Hsieh, C., Liu, C.J., Tseng, M. H., Lo, C. T. & Yang, Y. C. 2006. Effect of olive oil on the production of mycelial biomass and polysaccharides of Grifola frondosa under high oxygen concentration aeration, Enzyme and Microbial Technology, 39, 434-439.
62. Song, M., Kim, N., Lee, S. & Hwang, S. 2007. Use of whey permeate for cultivating Ganoderma lucidum mycelia, Journal of Dairy Science, 90, 2141-2146.
63. Lee, H., Song, M., Yu, Y. & Hwang, S. 2003b. Optimizing bioconversion of deproteinated cheese whey to mycelia of Ganoderma lucidum, Process Biochemistry, 38, 1685-1693.
64. Lee, H., Song, M., Yu, Y. & Hwang, S. 2003c. Production of Ganoderma lucidum mycelium using cheese whey as an alternative substrate: response surface analysis and biokinetics, Biochemical Engineering Journal, 15, 93-99.
65. Chang, M. Y., Tsai, G. J. & Houng, J. Y. 2006. Optimization of the medium composition for the submerged culture of Ganoderma lucidum by Taguchi array design and steepest ascent method. Enzyme and Microbial Technology, 38, 407-414.
66. Park, J. P., Kim, S. W., Hwang, H. J. & Yun, J. W. 2001. Optimization of submerged culture conditions for the mycelial growth and exo-biopolymer production by Cordyceps militaris, Letters in Applied Microbiology, 33, 76-81.
67. Habjanic, J. & Berovic, M. 2002. Process of cultivation of fungus Ganoderma lucidum on a solid cultivation substrate. Patent SI 20923. 2002 December 31.
68. Trinci, A. P. J, Wiebe, M. G. & Robson, G. D. 1994. Physiology of filamentous fungi. In: Modelling for improved bioreactor performance, 2. Modelling of filamentous fungi. International Conference, 15-16 September 1994, Otocec, Slovenia (edited by M. Berovic). Pp. 9. Ljubljana, Slovenia: National Institute of Chemistry Press.
69. Trinci, A. P. J. 1983. Effect of Julon on morphology of Aspergillus niger and its use in making turbidity measurements of fungal growth, Transactions of the British Mycological Society, 81, 408-412.
70. Byrne, G. S. & Ward O. P. 1987. Effect of polymers on pelleting of Rhizopus arrhizus, Transactions of the British Mycological Society, 89, 367-371.
71. Jones, P., Shabab B. A., Trinci, A. P. J. & Moore D. 1988. Effect of polymeric additives, especially Junlon and Hostacerin, on growth of some basidiomycetes in submerged culture, Transactions of the British Mycological Society, 90, 577-583.
72. Yang, F. C., Yang, M-J. & Cheng, S. H. 2009. A novel method to enhance the mycelia production of Ganoderma lucidum in submerged cultures by polymer additives and agitation strategies, Journal of the Taiwan Institute of Chemical Engineers, 40, 148-154.
73. Torres Lopez, A. M., Gaviria Soto, J. A., Quintero Diaz J. C., Atehortua Garces L., Rojas Vahos D. F. 2009. Characterization of the medicinal mushroom Ganoderma lucidum submerged culture in stirred tank, New Biotechnology, 25, S195-196.
74. Hirotani, M., Ino C., Furuya, T. & Shiro, M. 1986. Ganoderic acids T, S, and R, new triterpenoids from the cultured media of Ganoderma lucidum, Chemical & Pharmaceutical Bulletin, 34, 2282-2285.
75. Kikuchi, T., Kanomi, S., Murai, Y., Kadota, S., Tsubono, K. and Ogita, Z. 1986. Constituents of the fungus Ganoderma lucidum (Fr.) Karst. I. Structures of ganoderic acids C2, E, I, and K, lucidenic acid F and related compounds, Chemical & Pharmaceutical Bulletin, 34, 3695-3712.
76. Morigiwa, A., Kitabatake, K., Fujimoto, Y. & Ikekawa, N. 1986. Angiotensin converting enzyme inhibitory triterpenes from Ganoderma lucidum, Chemical & Pharmaceutical Bulletin, 34, 3025-3028.
77. Nishitoba, T., Sato, H. & Sakamura, S. 1987. Triterpenoids from the fungus Ganoderma lucidum, Phytochemistry, 26, 1777-1784.
78. Nishitoba, T., Goto, S., Sato, H. & Sakamura, S. 1989. Bitter triterpenoids from the fungus Ganoderma applanatum, Phytochemistry, 28, 193-197.
79. Lin, L. J. & Shiao, M. S. 1988a. Seven new triterpenes from Ganoderma lucidum, Journal of Natural Products, 51, 918-924.
80. Lin, L.J., Shiao, M.S. & Yeh, S.F. 1988b. Triterpenes from Ganoderma lucidum, Phytochemistry, 27, 2269-2271.
81. Shiao, M. S., Lin, L. J., Yeh, S. F. & Chou, C. S. 1987. Two new triterpenes of the fungus Ganoderma lucidum, Journal of Natural Products, 50, 886-890.
82. Chairul, Tokuyama, T., Hayashi, Y., Nishizawa, M., Tokuda, H., Chairul, S. M. & Hayashi, Y. 1991. Applanoxidic acids A, B, C and D, biologically active tetracyclic triterpenes from Ganoderma applanatum, Phytochemistry, 30, 4105-4109.
83. Chairul, Hayashi, Y., & Chairul, S. M. 1994. Lanostanoid triterpenes from Ganoderma applanatum, Phytochemistry, 35, 1305-1308.
84. Yang, M., Wang, X., Guan, S., Xia, J., Sun, J., Guo, H. & Guo, D. 2007. Analysis of triterpenoids in Ganoderma lucidum using liquid chromatography coupled with electrospray ionization mass spectrometry, Journal of the Americal Society for Mass Spectrometry, 18, 927-939.
85. Toth, J. O., Luu, B. & Ourisson, G. 1983. Les acides ganoderiques T a Z: triterpenes cytotoxiques de Ganoderma lucidum (Polyporaceae), Tetrahedron Letters, 24, 1081-1084.
86. Gao, J. J., Min, B. S., Ahn, E. M., Nakamura, N., Lee, H. K. & Hattori, M. 2002. New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells, Chemical & Pharmaceutical Bulletin (Tokyo), 50, 837-840.
87. Min, B. S., Gao, J. J., Nakamura, N. & Hattori, M. 2000. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells, Chemical & Pharmaceutical Bulletin (Tokyo), 48, 1026-1033.
88. Lin, S. B., Li, C. H., Lee, S. S. & Kan, L. S. 2003. Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activatedprotein kinases and G2-phase cell cycle arrest, Life Sciences, 72, 2381-2390.
89. Zhu, H. S., Yang, X. L., Wang, L. B., Zhao, D. X. and Chen, L. 2000. Effects of extracts from sporoderm-broken spores of Ganoderma lucidum on HeLa cells, Cell Biology and Toxicology, 16, 201-206.
90. Yu, S. P., Zhang, J. S., Tang, Q. J., Shi, X. M., Liu, Y. F., Yan, Y. & Pan, Y. L. 2004. Correlation between intracellular triterpenes from mycelia of Ganoderma lucidum in different growth stages and inhibition effect on tumor cells, Mycosystema, 23, 548-554.
91. Liu, J., Shimizu, K., Konishi, F., Noda, K., Kumamoto, S., Kurashiki, K. & Kondo, R. 2007. Anti-androgenic activities of the triterpenoids fraction of Ganoderma lucidum, Food Chemistry, 100, 1691-1696.
92. Mueller, C.I., Kumagai, T., Kelly, J.O., Seeram, N.P., Heber, D. & Koeffler, H.P. 2006. Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells, Leukemia Research, 30, 841-848.
93. Tang, W., Liu, J. W., Zhao. W. M., Wei, D. Z. & Zhong. J. J. 2006. Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells, Life Sciences, 80, 205-211.
94. Yuen J.W.M., Gohel M.D.J. 2008. The dual roles of Ganoderma antioxidants on urothelial cell DNA under carcinogenic attack. Journal of Ethnopharmacology, 118, 324-330.
95. Kohda, H., Tokumoto, W., Sakamoto, K., Fujii, M., Hirai, Y., Yamasaki, K., Komoda, Y., Nakamura, H., Ishihara, S. & Uchida, M. 1985. The biologically active constituents of Ganoderma lucidum (Fr.) Karst histamine release-inhibitory triterpenes, Chemical & Pharmaceutical Bulletin, 33, 1367-1374.
96. Kabir, Y., Kimura, S. & Tamura, T. 1988. Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hipertensive rats, Journal of Nutritional Science and Vitaminology, 34, 433-438.
97. Kim, D.H., Shim, S.B., Kim, N.J. & Jang, I.S. 1999. Beta-glucuronidase-inhibitory and hepatoprotective effect of Ganoderma lucidum, Biological and Pharmaceutical Bulletin, 22, 162-164.
98. Hattori, M., El-Mekkawy, S. & Meselhy, R. 1997. Inhibitory effects of components from Ganoderma lucidum on the growth of Human Immunodeficiency Virus (HIV) and the protease activity. In: Proceedings of the 1st International Symposium on Ganoderma lucidum in Japan, Nov 17-18 1997 (edited by T. Mizuno, N. Ide, & Y. Hasegawa). Pp.128-135.
99. El-Mekkawy, S., Meselhy, M. R., Nakamura, N., Tezuka, Y., Hattori, M., Kakiuchi, N., Shimotohno, K., Kawahata, T. & Otake, T. 1998.Anti-HIV-1 and anti-HIV-1 protease substances from Ganoderma lucidum, Phytochemistry, 49, 1651-1657.
100. Min, B. S., Nakamura, N., Miyashiro, H., Bae, K. W. & Hattori, M. 1998. Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease, Chemical & Pharmaceutical Bulletin, 46, 1607-1612.
101. Wang, C. N., Chen, J. C., Shiao, M. S. & Wang, C. T. 1989. The aggregation of human platelet induced by ganodermic acid, S. Biochimica et Biophysica Acta, 986, 151-160.
102. Su, C. Y., Shiao, M. S. & Wang, C. T. 1999. Predominant inhibition of ganodermic acid S on the thromboxane A2 -dependent pathway in human platelets response to collagen, Biochimica et Biophysica Acta, 1437, 223-234.
103. Su, C. Y, Shiao, M. S. & Wang, C. T. 2000. Potentiation of ganoderemic acid S on prostaglandin E(1)-induced cyclic AMP elevation in human platelets, Thrombosis Research, 99, 135-145.
104. Min, B. S., Gao, J. J., Hattori, M., Lee, H. K. & Kim, Y. H. 2001. Anticomplement activity of triterpenoids from the spores of Ganoderma lucidum, Planta Medica, 67, 811-814.
105. Kimura, Y., Taniguchi, M. & Baba, K. 2002. Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: Mechanism of action and isolation of an active substance, Anticancer Research, 22(6A), 3309-3318.
106. Lakshmi, B., Ajith, T. A., Jose, N. & Janardhanan, K.K. 2006. Antimutagenic activity of methanolic extract of Ganoderma lucidum and its effect on hepatic damage caused by benzo[a]pyrene, Journal of Ethnopharmacology, 107, 297-303.
107. Liu, J., Shimizu, K., Konishi, F., Kumamoto, S. & Kondo, R. 2007. The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum, Bioorganic & Medicinal Chemistry, 15, 4966-4972.
108. Ko, H. H., Hung, C.F., Wang, J. P. & Lin, C. N. 2008. Antiinflammatory triterpenoids and steroids from Ganoderma lucidum and G. tsugae, Phytochemistry, 69, 234-239.
109. Dudhgaonkar, S., Thyagarajan, A. & Sliva D. 2009. Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum, International Immunopharmacology, 9, 1272-1280.
110. Bao, X. F., Wang, X. S., Dong, Q., Fang, J. N. & Li, X. Y. 2002. Structural features of immunologically active polysaccharides from Ganoderma lucidum, Phytochemistry, 59, 175-181.
111. Li., Y.Q., Fang, L. & Zhang, K.C. 2007. Structure and bioactivities of a galactose rich, Carbohydrate Polymers, 68(2), 323-328.
112. Ye, L.B., Zhang, J.S., Yang, Y., Zhou, S., Liu, Y.F., Tang, Q.J., Du, X.J., Chen, H. & Pan, Y.J. 2009. Structural characterisation of a heteropolysaccharide by NMR spectra, Food Chemistry, 112, 962-966.
113. Guo, L., Xie, J., Ruan, Y., Zhou, L., Zhu, H., Yun, X., Jian, Y., Lu, L., Chen, K., Min, Z., Wen, Y. & Gu, J. 2009. Characterization and immunostimulatory activity of a polysaccharide from the spores of Ganoderma lucidum, International Immunopharmacology, 9, 1175-1182.
114. Russell, R. & Paterson, M. 2006. Ganoderma-A therapeutic fungal biofactory. Phytochemistry, 67, 1985-2001.
115. Wang, J. & Zhang, L., 2009. Structure and chain conformation of five water-soluble derivatives of a β-D-glucan isolated from Ganoderma lucidum, Carbohydrate Research, 344, 105-112
116. Lee, S. S., Chen, F. D., Chang, S. C., Wei, Y. H., Liu, I. & Chen, C. 1984. In vivo antitumor effect of crude extracts from the mycelium of Ganoderma lucidum, Journal of Chinese Oncology Society, 5, 22-27.
117. Hwang, S. F., Liu, K. J., Kuan, Y. H., Tung, K.S., Su, C. H. & Tung, T. C. 1989. The inhibitory effect on artificial pulmonary metastasis of murine S-180 Sarcoma cells by orally administered Ganoderma lucidum, Journal of Chinese Oncology Society, 5, 1015.
118. Furusawa, E., Chou, S.C., Furasawa, S., Hirazum, A. & Dang, Y. 1992. Antitumor activity of Ganoderma lucidum, an edible mushroom, on intraperitoneally implanted Lewis lung carcinoma in synergeneic mice, Phytotherapy Reearch, 6, 300-304.
119. Lu, H., Kyo, E., Uesaka, T., Katoh, O. & Watanabe, H. 2002. Prevention of development of N, N'-dimethylhydrazine-induced colon tumors by a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia in male ICR mice, International Journal of Molecular Medicine, 9, 113-117.
120. Liu, X., Yuan, J. P., Chuang, C. K. & Chen, X.J. 2002. Antitumor activity of the sporoderm-broken germinating spores of Ganoderma lucidum, Cancer Letters, 182, 155-161.
121. Lu, H., Kyo, E., Uesaka, T., Katoh, O. & Watanabe, H. 2003. A water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia suppresses azoxymethane-induction of colon cancers in male F344 rats, Oncology Reports, 10, 375-379.
122. Wang, S. Y., Hsu, M. L., Hsu, H. C., Tzeng, C. H., Lee, S. S., Shiao, M. S., & Ho, C. K. 1997. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes, International Journal of Cancer, 70, 699-705.
123. Hu, Y. H. & Lin, Z. B. 1999. Effects of polysaccharides isolated from mycelia of Ganoderma lucidum on HL-60 cell apoptosis, Acta Pharmacologica Sinica, 34, 268-271.
124. Hu, Y. H. & Lin, Z. B. 1999. Polysaccharides isolated from mycelia of Ganoderma lucidum induced HL-60 cell apoptosis by enhancing macrophage activity, Chinese Pharmacology Bulletin, 5, 27-30.
125. Lei, L. S., Li, M. C. & Sun, L. S. 2002. Ganoderma lucidum and its components on the function of macrophages. In Ganoderma: Genetics, chemistry, pharmacology and therapeutics, Proceedings of International symposium on Ganoderma research, October 21-23, 2002 (edited by Z.B. Lin). Pp. 20-23. Shanghai, China: Beijing, Medical University Press.
126. Cao, L. Z. & Lin, Z. B. 2003. Comparison of the effects of polysaccharides from wood-cultured and bag-cultured Ganoderma lucidum on murine spleen lymphocyte proliferation in vitro, Acta Pharmacologica Sinica, 38, 92-97.
127. Lee, S. S., Lee, P. L., Chen, C. F., Wang, S. Y. & Chen, K. Y. 2002. Antitumor effects of Ganoderma lucidum. In Ganoderma: Genetics, chemistry, pharmacology and therapeutics, Proceedings of International symposium on Ganoderma research, October 21-23, 2002 (edited by Z.B. Lin). Pp. 46-57. Shanghai, China: Beijing, Medical University Press.
128. Cao, L. Z. & Lin, Z. B. 2002. Regulation of Ganoderma lucidum polysaccharides on cytotoxic T lymphocytes induced by dendric cells in vitro. In Ganoderma: Genetics, chemistry, pharmacology and therapeutics, Proceedings of International symposium on Ganoderma research, October 21-23, 2002 (edited by Z.B. Lin). Pp. 122-129. Shanghai, China: Beijing, Medical University Press.
129. Boh, B., Berovic, M., Wraber, B., Hodzar, D., Habijanic, J., Pohleven, F. and Zore, I. 2004. Ganoderma lucidum (W.Curt.:Fr.) Lloyd and G. applanatum (Pers.) Pat. (Aphyllophoromycetideae) from Slovenian habitats: cultivation, isolation, and testing of active compounds, International Journal of Medicinal Mushrooms, 6, 15-32.
130. Chen, H. S., Tsai, Y. F., Lin, S., Lin, C. C., Khoo, K. H., Lin, C. H. & Wong, C. H. 2004. Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides, Bioorganic & Medicinal Chemistry, 12, 5595-5601.
131. Zhu, X. L. & Lin, Z. B. 2005. Effects of Ganoderma lucidum polysaccharides on proliferation and cytotoxicity of cytokine-induced killer cells, Acta Pharmacologica Sinica, 26, 1130-1137.
132. Zhu, X. L. & Lin, Z. B., 2006. Modulation of cytokines production, granzyme B and perforin in murine CIK cells by G. lucidum polysaccharides, Carbohydrate Polymers, 63, 188-197.
133. Lei, L., Lin, Z., Chen, Q., Li, R. & He, Y. 1993. Antagonistic effect of Ganoderma lucidum polysaccharide on the immunosuppressive response induced by cyclosporin A, hydrocortisone and antitumor agents, Chinese Journal of Pharmacology and Toxicology, 7, 183-185.
134. Zhu, X. L., Chen, A. F. & Lin, Z. B. 2007. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice, Journal of Ethnopharmacology, 111, 219-226.
135. Li, M., Lei, L. & Liang, D. 1999. Effect of Ganderma polysaccharide on intracellular free calcium in murine peritoneal macrophages, Chinese Pharmaceutical Journal, 34, 805-807.
136. Sadava, D., Still, D. W., Mudry, R. R. & Kane, S. E. 2009. Effect of Ganoderma on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells, Cancer Letters, 277, 182-189.
137. Cao, Q. Z. & Lin, Z. B. 2006. Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell, Life Sciences, 78, 1457-1463.
138. Song, Y. S., Kim, S. H., Sa, J. H., Jin, C., Lim, C. L. & Park, E. H. 2004. Anti-angiogenic and inhibitory activity on inducible nitric oxide production of the mushroom Ganoderma lucidum, Journal of Ethnopharmacology, 90, 17-20.
139. Stanley, G., Harvey, K., Slivova, V., Jiang, J. & Sliva, D., 2005. Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-β1 from prostate cancer cells, Biochemical and Biophyssical Research Communications, 330, 46-52.
140. Shi, Y. L., James, A. E., Benzie, I. F. F. & Bushwell, J. A. 2002. Mushroom derived preparations in the prevention of H2O2-induced oxidative damage to cellular DNA, Teratogenesis, Carcinogenesis, and Mutagenesis, 22, 103-111.
141. Pillai, T. G., Nair, C. K. K. & Janardhanan, K. K. 2010. Enhancement of repair of radiation induced DNA strand breaks in human cells by Ganoderma mushroom polysaccharides, Food Chemistry, 119, 1040-1043.
142. You, Y. H. & Lin, Z. B. 2002. Protective effects of Ganoderma lucidum polysaccharides peptide on injury of macrophages induced by reactive oxygen species, Acta Pharmacologica Sinica, 23, 878-791.
143. Zhang, H. N., He, J. H., Yuan, L. & Lin, Z. B. 2003. In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage, Life Sciences, 73, 2307-2319.
144. Lai, C. S. A., Yu, M. S., Yuen, W. H., So, K. F., Zee, S. Y. & Chang, R. C. C. 2008. Antagonizing β-amyloid peptide neurotoxicity of the anti-aging fungus Ganoderma lucidum, Brain Research, 1190, 215-224.
145. Lam, F. F. Y., Ko, I. W. M., Ng, E. S. K., Tam, L. S., Leung, P. C. & Li, E. K. M. 2008. Analgesic and anti-arthritic effects of Lingzhi and San Miao San supplementation in a rat model of arthritis induced by Freund's complete adjuvant, Journal of Ethnopharmacology, 120, 44-50.
146. Jia, J., Zhang, J. J., Hu, Y. S., Wu, Y., Wang, Q. Z., Li, N. N., Guo, Q. C. & Dong, X. C. 2009. Evaluation of in vivo antioxidant activities of Ganoderma lucidum polysaccharides in STZ-diabetic rats, Food Chemistry, 115, 32-36.
147. Seto, S. W., Lam, T. Y., Tam, H. L., Au, A. L. S., Chan, S. W., Wu, J. H., Yu, P. H. F., Leung, G.P.H., Ngai, S.M., Yeung, J.H.K., Leung, P.S., Lee, S. M. Y. & Kwan, Y. W. 2009. Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice, Phytomedicine, 16, 426-436.
148. Ping, C. X., Yan, C., Bing, L. S., Guo, C. Y., Yun, L. J. & Ping, L. L. 2009. Free radical scavenging of Ganoderma lucidum polysaccharides and its effect on antioxidant enzymes and immunity activities in cervical carcinoma rats, Carbohydrate Polymers, 77, 389-393.
149. Guo, C. Y., Ji, S. Z. & Ping, C. X. 2009. Modulatory effect of Ganoderma lucidum polysaccharides on serum antioxidant enzymes activities in ovarian cancer rats, Carbohydrate Polymers, 78, 258-262.
150. Zhang, J. S, Tang, Q. J., Zimmerman-Kordmann, M., Reuter, W. & Fan, H. 2002. Activation of B lymphocytes by GLIS, a bioactive proteoglycan from Ganoderma lucidum, Life Sciences, 71, 623-638.
151. Wang, Y. Y., Khoo, K. H., Chen, S. T., Lin, C. C., Wong, C. H. & Lin, C. H. 2002. Studies on the immuno-modulating and antitumor activities of Ganoderma lucidum (Reishi) polysaccharides: functional and proteomic analyses of a fucose-containing glycoprotein fraction responsible for the activities. Bioorganic & Medicinal Chemistry, 10, 1057-1062.
152. Liu, J., Yang, F., Ye, L. B., Yang, X.J., Timani, K. A., Zheng, Y. & Wang, Y. H. 2004. Possible mode of action of antiherpetic activities of a proteoglycan isolated from the mycelia of Ganoderma lucidum in vitro, Journal of Ethnopharmacology, 95, 256-272.
153. Wang, H. X., Ng, T. B. & Chiu, S. W. 2004. A distinctive ribonuclease from fresh fruiting bodies of the medicinal mushroom Ganoderma lucidum, Biochemical and BiophysicalRessearch Communications, 314, 519-522.
154. Tian, Y. P. & Zhang, K. C. 2005. Purification and characterization of a novel proteinase A inhibitor from Ganoderma lucidum by submerged fermentation, Enzyme and Microbial Technologynology, 36, 357-361.
155. Wang, H. X. & Ng, T. B. 2006. Ganodermin, an antifungal protein from fruiting bodies of the medicinal mushroom Ganoderma lucidum, Peptides, 27, 27-30.
156. Thakur, A., Rana, M., Lakhanpal, T. N., Ahmad, A. & Khan, M. I., 2007. Purification and characterization of lectin from fruiting body of Ganoderma lucidum Lectin from Ganoderma lucidum, Biochimica et Biophysica Acta, 1770, 1404-1412.
157. Ye, L. B., Zhang, J. S., Ye, X. Y., Tang, Q. J., Liu, Y. F., Gong, C. Y., Du, X. J. & Pan Y. J. 2008. Structural elucidation of the polysaccharide moiety of a glycopeptide (GLPCW-II) from Ganoderma lucidum fruiting bodies, Carbohydrate Research, 343, 746-752.
158. Shi, Y., Sun, J., He, H, Guo, H. & Zhang, S. 2008. Hepatoprotective effects of Ganoderma lucidum peptides against D-galactosamine-induced liver injury in mice, Journal of Ethnopharmacology, 117, 415-419.
159. Ye, L., Li, J., Zhang, J. & Pan, Y. 2010. NMR characterization for polysaccharide moiety of a glycopeptide, Fitoterapia, 81, 93-96.
160. Ziegenbein, F. C., Hanssen, H. P. & Konig, W. A. 2006. Secondary metabolites from Ganoderma lucidum and Spongiporus leucomallellus, Phytochemistry, 67, 202-211.
161. Wasser, S. P. & Weiss, A. L. 1997. Medicinal mushrooms-Ganoderma lucidum, Reishi mushroom. Haifa, Israel: Pedeifus Publishing House. (no page number)
162. Chang, S. T. & Buswell, J. A. 1996. Mushroom nutriceuticals, World Journal of Microbiology and Biotechnology, 12, 473-476.
163. Sanodiya, B. S., Thakur, G. S., Baghel, R. K., Prasad, G. B. & Bisen, P. S. 2009. Ganoderma lucidum: a potent pharmacological macrofungus, Current Pharmaceutical Biotechnology, 10, 717-42.
164. Zhang, C. Y. & Li, Y. M. 2002. Clinical investigation of Green Valley Lingzhi capsule on type 2 diabetes mellitus. In Ganoderma: Genetics, chemistry, pharmacology and therapeutics, Proceedings of International symposium on Ganoderma research, October 21-23, 2002 (edited by Z.B. Lin). Pp. 194-198. Shanghai, China: Beijing, Medical University Press.
165. Shi, K. G. & Quing, L. H. 2002. The follow-up observation assessment of medium and late phases cancer treated by Chinese Ganoderma lucidum essence (CGLE). In Ganoderma: Genetics, chemistry, pharmacology and therapeutics, Proceedings of International symposium on Ganoderma research, October 21-23, 2002 (edited by Z.B. Lin). Pp. 188-193. Shanghai, China: Beijing, Medical University Press.
166. Gao, Y., Zhou, S., Jiang, W., Huang, M. & Dai, X. 2003. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients, Immunological Investigations, 32, 201-15.
167. Gao, Y., Tang, W., Dai, X., Chen, G., Ye, J., Chen, E., Koh, H. L., Li, X. & Zhou, S. 2005. Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer, Journal of Medicinal Food, 8, 159-68.
168. Noguchi, M., Kakuma, T., Tomiyasu, K., Konishi, F., Kumamoto, S., Kondo, R., Matsuoka, K. 2005. Phase I study of a methanol extract of Ganoderma lucidum, edible and medicinal mushroom, in men with mild symptoms of bladder outlet obstruction, Urology, 66, Supplement3A, 21.
169. Chen, X., Hu, Z. P., Yang, X. X., Huang, M., Gao, Y., Tang, W., Chan, S. Y., Dai, X., Ye, J., Ho, P.C., Duan, W., Yang, H. Y., Zhu, Y. Z. & Zhou, S. F. 2006. Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancer, International Immunopharmacology, 6, 499-508.
170. Chan, W. K., Lam, D. T., Law, H. K., Wong, W. T., Leung, K. M. W., Lau, Y. L. & Chan, G. C. 2005. Ganoderma lucidum mycelium and spore extracts as natural adjuvants for immunotherapy, Journal of Alternative and Complementary Medicine, 11, 1047-57.
171. Noguchi, M., Kakuma, T., Tomiyasu, K., Itoh, K., Konishi, F., Kumamoto, S., Shimizu, K., Kondo, R. & Matsuoka, K. 2007. A randomized clinical trial of an ethanol extract of Ganoderma lucidum (edible and medicinal mushroom) in men with lower urinary tract symptoms, Urology, 70, Supplement 3A, 254.
172. Yuen, M. F., Ip, P., Ng, W. K. & Lai, C. L. 2004. Hepatotoxicity due to a formulation of Ganoderma lucidum (lingzhi). Letters to the editor, Journal of Hepatology, 41, 685-690.
173. eHow, 2010. Side Effects of Ganoderma lucidum. URL http://www.ehow.com/facts_5021871_side-effects-ganoderma-lucidum.html. Accessed 19/2/2010.